Influenza News and Research

Latest Influenza News and Research

Deaths of Chinese children, adolescents from infectious diseases prior to COVID-19 found to be rare

Deaths of children and adolescents in China due to infectious diseases were becoming rare prior to the COVID-19 pandemic, according to a new study.

3 Apr 2020

First genome sequences of SARS-CoV-2 viruses in Austria openly available

The first 21 SARS-CoV-2 genomes in Austria have now been completed and published within the scope of the “Mutational Dynamics of SARS-CoV-2” project recently launched by CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, in close collaboration with the Medical University of Vienna.

3 Apr 2020

Australian scientists identify possible coronavirus drug

A collaborative study led by Monash University's Biomedicine Discovery Institute in Melbourne, Australia, with the Peter Doherty Institute of Infection and Immunity, has shown that an anti-parasitic drug already available around the world kills the virus within 48 hours.

3 Apr 2020

COVID-19 by the numbers

Numerical data sometimes reveal facts that are otherwise concealed within an onslaught of information from an overwhelming number of sources.

2 Apr 2020

How (easily) does the novel coronavirus spread?

Viruses are tiny bundles of DNA or RNA which have the ability to infect host cells, hijack the machinery of the host cell and then replicate. Once the host cell’s resources are exhausted, the viral particles are released to infect other cells. In this way, the viruses ensure their survival, often at the expense of the host.

1 Apr 2020

Putting an end to the pandemic

From the plagues of medieval Europe to the influenza pandemic of 1918, the specter of the next public health disaster has gripped the minds of scientists, captivated the imaginations of writers and vexed conspiracy theorists.

1 Apr 2020

Measuring the severity of COVID-19 using a model-based analysis

Researchers have modeled the progression and severity of COVID-19. Their study titled “Estimates of the severity of coronavirus disease 2019: a model-based analysis” was published in the latest issue of The Lancet Infectious Diseases.

1 Apr 2020

Estimating the case fatality ratio for COVID-19

The Severe Acute Respiratory Syndrome Corona Virus (SARS-CoV-2) that causes COVID-19 disease has affected 932,605 individuals and has taken 46,809 lives worldwide. Now, researchers have published a review on the likelihood of survival after SARS-CoV-2 infection. The study titled, “Likelihood of survival of coronavirus disease 2019” is published in the latest issue of The Lancet Infectious Diseases.

1 Apr 2020

Phoseon’s KeyPro products use high-intensity UV light to fight against pathogens

Phoseon’s KeyPro™ family of products uses high-intensity, deep ultraviolet light to disinfect and decontaminate laboratory equipment and surfaces. Independent testing has shown efficacy of KeyPro against viruses, bacteria, fungi, and biomolecules like ribonuclease.

From Phoseon Technology 1 Apr 2020

New Vivalytic Viral Respiratory Tract Infection Array can identify SARS-CoV-2 virus

A game-changing point of care coronavirus test from global diagnostics company Randox Laboratories and leading technology manufacturer Bosch Healthcare Solutions will launch in April 2020.

From Randox Laboratories Ltd. 1 Apr 2020

Blood centers will collect plasma from COVID-19 survivors in bid for treatment

Blood donation centers across the U.S. are ramping up efforts to collect plasma from people who have recovered from COVID-19 in hopes it could be used to save the lives of others infected with the pandemic disease.

1 Apr 2020

Should you bring mom home from assisted living during the pandemic?

Dr. Alison Webb took her 81-year-old father out of assisted living, to live.

31 Mar 2020

Eight strains of coronavirus afflicting the world

Scientists around the world are racing to study the novel coronavirus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Now, it appears that there are eight strains of SARS-CoV-2 circulating the globe. The good news is that according to infectious disease physician and clinical microbiologist Charles Chiu, “The virus mutates so slowly that the virus strains are fundamentally very similar to each other.”

31 Mar 2020

World academies urge scientific, policymaking communities to help control COVID-19

The current COVID-19 outbreak was first reported on 31 December 2019. On 11 March 2020 the World Health Organization (WHO) declared a pandemic.

31 Mar 2020

Researchers develop chemically modified phage capsid that “stifles” influenza viruses

A new approach brings the hope of new therapeutic options for suppressing seasonal influenza and avian flu: On the basis of an empty - and therefore non-infectious - shell of a phage virus, researchers from Berlin have developed a chemically modified phage capsid that "stifles" influenza viruses.

31 Mar 2020

UAB will collaborate with Altimmune to test a COVID-19 vaccine candidate

The University of Alabama at Birmingham is launching a collaboration with the biopharmaceutical company Altimmune, Inc. for preclinical testing of a potential vaccine to prevent COVID-19 disease.

30 Mar 2020

What takes so long? A behind-the-scenes look at the steps involved in COVID-19 testing

After a slow start, testing for COVID-19 has ramped up in recent weeks, with giant commercial labs jumping into the effort, drive-up testing sites established in some places and new types of tests approved under emergency rules set by the Food and Drug Administration.

30 Mar 2020

Researchers enlist the help of citizen scientists to design new drugs against coronavirus

The best thing most of us can do to fight COVID-19 is stay home, to curb the respiratory disease's spread. But anyone with a computer can pitch in more actively too: by helping scientists design drugs to combat the virus now responsible for hundreds of thousands of infections worldwide.

27 Mar 2020

UC Davis launches two clinical trials to evaluate treatments for COVID-19

UC Davis Health has two clinical trials underway for hospitalized patients with severe COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2.

27 Mar 2020

Elsevier’s analysis on global research trends in infectious diseases

Over the past two decades, the world has faced several infectious disease outbreaks. Ebola, Influenza A (H1N1), SARS, MERS, Zika virus and currently COVID-19 have had a massive global impact in terms of economic disruption, strain on local and global public health resources and, above all, human health.

From Elsevier 27 Mar 2020

Influenza News and Research

Latest Influenza News and Research

Deaths of Chinese children, adolescents from infectious diseases prior to COVID-19 found to be rare

First genome sequences of SARS-CoV-2 viruses in Austria openly available

Australian scientists identify possible coronavirus drug

COVID-19 by the numbers

How (easily) does the novel coronavirus spread?

Putting an end to the pandemic

Measuring the severity of COVID-19 using a model-based analysis

Estimating the case fatality ratio for COVID-19

Phoseon’s KeyPro products use high-intensity UV light to fight against pathogens

New Vivalytic Viral Respiratory Tract Infection Array can identify SARS-CoV-2 virus

Blood centers will collect plasma from COVID-19 survivors in bid for treatment

Should you bring mom home from assisted living during the pandemic?

Eight strains of coronavirus afflicting the world

World academies urge scientific, policymaking communities to help control COVID-19

Researchers develop chemically modified phage capsid that “stifles” influenza viruses

UAB will collaborate with Altimmune to test a COVID-19 vaccine candidate

What takes so long? A behind-the-scenes look at the steps involved in COVID-19 testing

Researchers enlist the help of citizen scientists to design new drugs against coronavirus

UC Davis launches two clinical trials to evaluate treatments for COVID-19

Elsevier’s analysis on global research trends in infectious diseases

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Influenza News and Research

Latest Influenza News and Research

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in